MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Cardiovascular Systems Operating Expenses 2011-2026 | CSII
Annual Operating Expenses Cardiovascular Systems
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 209 M | 210 M | 215 M | 201 M | 175 M | 167 M | 188 M | 175 M | 139 M | 102 M | 77.7 M | 71.3 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 215 M | 71.3 M | 161 M |
Quarterly Operating Expenses Cardiovascular Systems
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.5 M | 53.9 M | 105 M | 51.1 M | 49.6 M | 52.2 M | 102 M | 54.9 M | 50 M | 49.6 M | 50 M | 51.7 M | 58 M | 57.8 M | 58 M | 57.8 M | 48.3 M | 48.7 M | 48.3 M | 48.7 M | 43.4 M | 42.2 M | 43.4 M | 42.2 M | 39.8 M | 42.2 M | 39.8 M | 42.2 M | 48.5 M | 48.3 M | 48.5 M | 48.3 M | 40.6 M | 40.7 M | 40.6 M | 40.7 M | 32.5 M | 29.7 M | 32.5 M | 29.7 M | 24.5 M | 23.2 M | 24.5 M | 23.2 M | 18.8 M | 17.4 M | 18.8 M | 17.4 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 105 M | 17.4 M | 44.4 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M |  USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
41.6 M | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
53.7 M | $ 3.92 | -1.51 % | $ 136 M | USA |
 |
Alphatec Holdings
ATEC
|
560 M | $ 13.47 | -3.09 % | $ 1.93 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
293 M | $ 7.2 | -6.13 % | $ 517 M |  Israel |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.03 B | $ 293.69 | -2.09 % | $ 8.29 B | USA |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 42.43 | 2.04 % | $ 6.32 K | USA |
 |
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
CONMED Corporation
CNMD
|
533 M | $ 42.33 | - | $ 1.31 B | USA |
 |
Boston Scientific Corporation
BSX
|
8.89 B | $ 73.47 | - | $ 108 B | USA |
 |
Abbott Laboratories
ABT
|
14.1 B | $ 113.59 | - | $ 198 B | USA |
 |
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 13.37 | - | $ 361 M | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 4.9 | 6.52 % | $ 183 M |  France |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
40.3 M | $ 25.26 | - | $ 214 M | USA |
 |
InMode Ltd.
INMD
|
136 M | $ 14.24 | -2.6 % | $ 1.13 B | Israel |
 |
IRadimed Corporation
IRMD
|
34.4 M | $ 103.08 | -1.97 % | $ 1.31 B | USA |
 |
Second Sight Medical Products
EYES
|
24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 18.58 | -0.69 % | $ 122 M | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Integer Holdings Corporation
ITGR
|
251 M | $ 87.18 | 1.2 % | $ 2.93 B | USA |
 |
Globus Medical
GMED
|
547 M | $ 88.26 | -0.52 % | $ 12 B | USA |
 |
Pulmonx Corporation
LUNG
|
120 M | $ 1.45 | - | $ 56.7 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
794 M | $ 11.18 | 1.82 % | $ 861 M | USA |
 |
Establishment Labs Holdings
ESTA
|
160 M | $ 72.72 | 0.19 % | $ 2.05 B |  Costa-rica |
 |
Medigus Ltd.
MDGS
|
4.02 M | - | 10.28 % | $ 55.5 M | Israel |
 |
IRIDEX Corporation
IRIX
|
31.8 M | $ 1.43 | - | $ 23.1 M | USA |
 |
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | USA |
 |
Cytosorbents Corporation
CTSO
|
41.9 M | $ 0.62 | -7.43 % | $ 33.7 M | USA |
 |
Profound Medical Corp.
PROF
|
33 M | $ 6.44 | 1.26 % | $ 180 M | Canada |